Influenza Virus - A Multicenter Registry
NCT01256255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 282
Last updated 2022-06-01
Summary
The investigators purpose is to prospectively characterize influenza infections over a 3 year period in transplant patients using a registry system. The investigators plan to generate robust data on clinical features of upper and lower respiratory disease, antiviral therapy and its effects on disease outcome, as well as quantitative virologic data on shedding and antiviral resistance. The investigators also will study the long term sequelae of influenza infections and look at development of rejection.
Conditions
- Influenza Infection in Transplant Patients
Sponsors & Collaborators
-
University of Alberta
lead OTHER
Principal Investigators
-
Deepali Kumar, MD · University of Alberta
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2013-08-31
- Completion
- 2014-01-27
Countries
- Canada
Study Locations
More Related Trials
-
Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant Recipients
NCT01180699 ·Status: COMPLETED ·Phase: NA
-
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
NCT00402805 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine in Lung Transplant Patients
NCT00205270 ·Status: COMPLETED
-
Influenza Vaccine in Lung Transplant Patients - Seroprotection
NCT04531657 ·Status: COMPLETED
-
Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients
NCT00760175 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
NCT04531787 ·Status: COMPLETED
-
DMID 21-0041; Influenza CVD 59000
NCT05666245 ·Status: COMPLETED ·Phase: NA
-
Adjuvanted Influenza Vaccine in Stem Cell Transplant
NCT02560909 ·Status: COMPLETED ·Phase: PHASE4
-
Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection
NCT02597647 ·Status: COMPLETED ·Phase: PHASE1
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
NCT05215327 ·Status: RECRUITING ·Phase: PHASE2
-
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
NCT04530786 ·Status: COMPLETED
-
Novel Influenza A (H1N1) Surveillance Registry
NCT01046331 ·Status: COMPLETED
-
Influenza Vaccine in Lung Transplant Patients - T Cells
NCT04533061 ·Status: COMPLETED
-
Pilot Study of Genotypic Analysis
NCT00421837 ·Status: COMPLETED
-
Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
NCT01011582 ·Status: COMPLETED
-
Immune Response to Influenza Vaccination
NCT00551837 ·Status: COMPLETED
-
Early Flu Shots in SOT
NCT03327987 ·Status: WITHDRAWN
-
Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults
NCT00998803 ·Status: COMPLETED
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
A Retrospective, Observational Registry of Participants With Avian Influenza Infection
NCT02743676 ·Status: COMPLETED
-
Hutterite Influenza Prevention Study
NCT00877396 ·Status: COMPLETED ·Phase: PHASE4
-
High Dose vs. Standard Influenza Vaccine in Adult SOT
NCT03139565 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine in Lung Transplant Patients - Antibody
NCT04533139 ·Status: COMPLETED
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda
NCT01916759 ·Status: COMPLETED ·Phase: NA